|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 282, Issue 18, 13151-13159, May 4, 2007
Specificity of L,D-Transpeptidases from Gram-positive Bacteria Producing Different Peptidoglycan Chemotypes*![]() ¶![]() ¶![]() ¶||![]() ¶![]() ¶![]() ¶![]() ¶![]() ![]() ![]() ¶1
From the
Received for publication, November 27, 2006 , and in revised form, January 18, 2007.
We report here the first direct assessment of the specificity of a class of peptidoglycan cross-linking enzymes, the L,D-transpeptidases, for the highly diverse structure of peptidoglycan precursors of Gram-positive bacteria. The lone functionally characterized member of this new family of active site cysteine peptidases, Ldtfm from Enterococcus faecium, was previously shown to bypass the D,D-transpeptidase activity of the classical penicillin-binding proteins leading to high level cross-resistance to glycopeptide and -lactam antibiotics. Ldtfm homologues from Bacillus subtilis (LdtBs) and E. faecalis (Ldtfs) were found here to cross-link their cognate disaccharide-peptide subunits containing meso-diaminopimelic acid (mesoDAP3) and L-Lys3-L-Ala-L-Ala at the third position of the stem peptide, respectively, instead of L-Lys3-D-iAsn in E. faecium. Ldtfs differed from Ldtfm and LdtBs by its capacity to hydrolyze the L-Lys3-D-Ala4 bond of tetrapeptide (L,D-carboxypeptidase activity) and pentapeptide (L,D-endopeptidase activity) stems, in addition to the common cross-linking activity. The three enzymes were specific for their cognate acyl acceptors in the cross-linking reaction. In contrast to Ldtfs, which was also specific for its cognate acyl donor, Ldtfm tolerated substitution of L-Lys3-D-iAsn by L-Lys3-L-Ala-L-Ala. Likewise, LdtBs tolerated substitution of mesoDAP3 by L-Lys3-D-iAsn and L-Lys3-L-Ala-L-Ala in the acyl donor. Thus, diversification of the structure of peptidoglycan precursors associated with speciation has led to a parallel evolution of the substrate specificity of the L,D-transpeptidases affecting mainly the recognition of the acyl acceptor. Blocking the assembly of the side chain could therefore be used to combat antibiotic resistance involving L,D-transpeptidases.
The bacterial cell wall peptidoglycan is a net-like macromolecule that surrounds the cytoplasmic membrane (1). The polymer is essential because it supplies the cell with mechanical protection against the osmotic pressure of the cytoplasm. The peptidoglycan subunit contains -1,4-linked N-acetylglucosamine (GlcNAc)2 and N-acetylmuramic acid (MurNAc) substituted by a peptide stem (Fig. 1A) (2). Assembly of the subunit at the cell surface is performed by glycosyltransferases that polymerize the glycan strands by formation of -1,4 bonds and D,D-transpeptidases that cross-link glycan strands (2). The latter reaction is catalyzed by penicillin-binding proteins (PBPs) that cleave the D-Ala4-D-Ala5 bond of a donor stem pentapeptide and link the carbonyl of D-Ala4 to the amino group of the side chain carried by the third residue of an acceptor stem peptide (Fig. 1B). This two-step reaction involves formation of a covalent adduct between the -hydroxyl of the active site serine of the PBPs and the carbonyl of D-Ala4 of the donor stem (3). The glycosyltransferase and D,D-transpeptidase activities of the multimodular peptidoglycan polymerases are the targets of the two major classes of antibiotics available to treat severe infections due to Gram-positive bacteria, the -lactams and the glycopeptides, that act by different mechanisms. The -lactams are structural analogues of D-Ala4-D-Ala5 and act as suicide substrates of the D,D-transpeptidase module of the PBPs. The glycopeptides bind to the peptidyl-D-Ala4-D-Ala5 extremity of peptidoglycan precursors and block by steric hindrance both the transglycosylation and transpeptidation reactions (4).
The assembly pathway of peptidoglycan precursors and its mode of polymerization are generally highly conserved in eubacteria. Variations in the structure of peptidoglycan subunits involve mainly the fifth (C-terminal) and third positions of the pentapeptide stem (5). The specificity of peptidoglycan cross-linking enzymes for the donor is the bottleneck that limits emergence of resistance to glycopeptides because the modifications of the precursors that prevent drug binding should be tolerated by these enzymes (4, 6). Successful modifications that have spread in Gram-positive pathogens under the selective pressure of glycopeptides include incorporation of D-lactate or D-Ser instead of D-Ala at the fifth position of pentapeptide stems (7). Strikingly, production of D-lactate-ending precursors can also have an impact on the activity of
Variation at the third position of the peptide stem concerns both the nature of the diamino acid present at this position, e.g. L-Lys or meso-diaminopimelic acid (mesoDAP), and the presence or absence of a side chain comprising from one to five amino acids (5) (Fig. 1A). Glycine and L-amino acids are incorporated into the side chain of peptidoglycan precursors by transferases of the Fem family that use aminoacyl-tRNAs as the substrate (11). D-Aspartic acid is activated as
Interaction of the peptidoglycan cross-linking enzymes with their substrates has not been extensively investigated, despite its pivotal role for drug development and for our understanding of the mechanisms of resistance to glycopeptides and
Production and Purification of L,D-TranspeptidasesA catalytically active fragment of Ldtfm from E. faecium M512 (residues 119466) was produced in E. coli and purified by affinity, anion exchange, and size exclusion chromatographies, as previously described (18). A fragment of the open reading frame encoding residues 136474 of the L,D-transpeptidase of E. faecalis strain JH2-2 (19), Ldtfs, was amplified with primers 5'-AACCATGGGGAGTATCCGTCGAGGCAATGG-3' and 5'-AAGGATCCTACTTCTTCGCCGTAATCTA-3'. The PCR product was digested with NcoI and BamHI (underlined) and cloned into pET2818, a derivative of pET2816 (18) lacking the sequence specifying the thrombin cleavage site. The resulting plasmid, pET2818 ldtfs, was introduced in E. coli BL21(DE3) harboring pREP4GroESL (20), and bacteria were grown at 37 °C to an optical density at 600 nm of 0.8 in brain heart infusion broth (Difco, Elancourt, France) containing ampicillin (100 µg/ml). Isopropyl- -D-thiogalactopyranoside was added to a final concentration of 0.5 mM, and incubation was continued for 17 h at 16 °C. The cells were disrupted by sonication in 50 mM Tris-HCl, pH 7.5, containing 300 mM NaCl, and cell debris were removed by centrifugation. Ldtfs was purified from the resulting clarified lysate by affinity chromatography on Ni2+-nitrilotriacetate-agarose resin (Qiagen GmbH, Hilden, Germany). Proteins eluted with 200 mM imidazole were dialyzed against 50 mM Tris-HCl, pH 8.0, containing 60 mM NaCl, loaded onto an anion exchange column (MonoQ HR5/5, Amersham Biosciences) equilibrated with the same buffer. Ldtfs, eluting at 300 mM NaCl, was further purified by size exclusion chromatography on a Superdex HR10/30 column (Amersham Biosciences) equilibrated with 50 mM Tris-HCl, pH 7.5, containing 300 mM NaCl. The protein was obtained with an overall yield of 3 mg/liter of culture, as estimated by the Bio-Rad protein assay using bovine serum albumin as a standard. The protein was stored at 80 °C in 50 mM Tris-HCl, pH 7.5, containing 300 mM NaCl. The open reading frame encoding the L,D-transpeptidase of B. subtilis strain 168, LdtBs, previously named ykuD (21), was amplified with primers 5'-AACCATGGGGCTGCTTACGTACCAGGTGAAGC-3' and 5 '-TTGGATCCCCGGTTAATCGTGACTCTCGT-3'. The PCR product digested with NcoI and BamHI (underlined) was cloned into pET2818, and LdtBs was produced in E. coli BL21(DE3)/pREP4GroESL using the inducing conditions described above for the L,D-transpeptidase of E. faecalis. LdtBs was purified in one step by affinity chromatography on Ni2+-nitrilotriacetate-agarose resin (Qiagen), dialyzed against 50 mM Tris-HCl, pH 7.5, containing 100 mM NaCl, and stored at 20 °C in the same buffer. 10 mg of protein were obtained per liter of culture. L,D-Transpeptidase AssaysThe source of the disaccharide-peptides used as substrates was as follows. The disaccharide-tetrapeptide substituted by a D-iso-asparagine residue (L-Lys3-D-iAsn) was purified from the peptidoglycan of E. gallinarum strain SC1 (22). The disaccharide-pentapeptide and the disaccharide-tetrapeptide substituted by an L-Ala-L-Ala side chain (L-Lys3-L-Ala-L-Ala) were purified from E. faecalis JH2-2 (19) and from a derivative of strain JH2-2 harboring the vanA glycopeptide resistance gene cluster (23), respectively. The disaccharide-tetrapeptide containing meso-diaminopimelic acid (mesoDAP3) was purified from E. coli strain ATCC 25113. The procedures used for peptidoglycan preparation, digestion with muramidases, and reduction of MurNAc to muramitol with sodium borohydride have been previously described for enterococci (24) and E. coli (25). The resulting muropeptides were separated by RP-HPLC in acetonitrile gradients containing trifluoroacetic acid (24) and identified by mass spectrometry (MS). The concentration of the muropeptides was estimated by amino acid analysis after acidic hydrolysis with a Hitachi autoanalyzer (26). In vitro formation of muropeptide dimers was tested in 10 µl of phosphate buffer (20 mM, pH 7.0) containing the L,D-transpeptidase (7 µM) from E. faecium (Ldtfm), E. faecalis (Ldtfs), or B. subtilis (LdtBs) and a combination of three reduced disaccharide-tetrapeptides (200 µM each) containing L-Lys3-D-iAsn, L-Lys3-L-Ala-L-Ala, or mesoDAP3 at the third position of a tetrapeptide stem. The reaction was incubated for 2 h at 37°C, desalted using a micro column (ZipTipC18; Millipore, Saint Quentin-en-Yvelines, France), and analyzed by nanoelectrospray MS in the positive mode (Qstar Pulsar I; Applied Biosystem, Courtaboeuf, France). The sequence of the cross-links in dimers generated in vitro was determined by tandem mass spectrometry (MS/MS). Briefly, dimers were generated in vitro as described above except that the disaccharide-peptides used as substrates were not reduced. The reaction mixture was treated with ammonium hydroxide, desalted using a micro column (ZipTipC18, Millipore), and the resulting lactoyl-peptides were analyzed by nanoelectrospray MS/MS using N2 as the collision gas (24). The L,D-transpeptidase activity of Ldtfs was also tested by using the dipeptides L-Ala-L-Ala and D-Ala-D-Ala as acyl acceptors. The assay performed in 10 µl of 20 mM potassium phosphate buffer, pH 7.0, contained Ldtfs (7 µM), the cognate disaccharide-tetrapeptide containing an L-Ala-L-Ala side chain as the acyl donor (200 µM), and 1 mML-Ala-L-Ala or D-Ala-D-Ala (Sigma). The products of the reactions were identified by MS and MS/MS, as previously described (18).
Expression of the bppA1 Gene of E. faecalis in E. faecium M512 and Analysis of Peptidoglycan StructureThe bppA1 gene of plasmid pDA15 (27) was subcloned under the control of the inducible promoter of pJEH4 (12) using XbaI and KpnI. The resulting plasmid, pJEH6(bppA1), was introduced by electroporation into E. faecium M512 (10). The recombinant strain was grown in brain heart infusion broth or agar (Difco) containing spectinomycin (120 µg/ml) to counter select loss of pJEH6(bppA1). Induction of the bppA1 gene was performed with 0.3 mM isopropyl-
Probing the Substrate Specificity of Ldtfm in VivoSynthesis of the side chain of peptidoglycan precursors is catalyzed in E. faecalis by two members of the Fem family, BppA1 and BppA2, that sequentially add two L-Ala residues (Fig. 1A) (23). In E. faecium, D-Asp is added to the precursors by the Aslfm ligase and subsequently partially amidated (12). The bppA1 gene of E. faecalis was cloned under the control of an inducible promoter to generate plasmid pJEH6 and introduced into E. faecium M512 in order to manipulate the structure of the substrate of the cross-linking reaction that can be catalyzed in this mutant by Ldtfm and by the PBPs (28). The BppA1 transferase efficiently competed with the Aslfm ligase in E. faecium M512/pJEH6(bppA1) because the main monomers contained L-Ala instead of D-iAsp (Fig. 2, peaks 1 and 2). The free side chains in the major dimers generated by L,D- and D,D-transpeptidation also contained L-Ala, indicating that Ldtfm, as the PBPs, had catalyzed cross-link formation using donors containing this residue (Fig. 2, peaks 35). The cross-links of dimers generated by L,D-transpeptidation exclusively contained D-iAsp, whereas D-iAsp or L-Ala was found in cross-links generated by D,D-transpeptidation. Thus, Ldtfm tolerated the substitution only in the donor substrate, in contrast to the PBPs that catalyzed peptidoglycan cross-linking with modified donor and acceptor substrates. Modifications of the side chain of peptidoglycan precursors were also shown to be tolerated by PBPs of E. faecalis and S. aureus in previous studies (12, 24). Ldtfm Is Also Specific for D-iAsn-substituted Acceptors in VitroThe specificity of Ldtfm was analyzed by incubating the enzyme with three disaccharide-tetrapeptides obtained by digestion of peptidoglycan of three different chemotypes with muramidases. The substrates were representative of the main variations found at the third position of peptidoglycan precursors of Gram-positive bacteria including the absence of a side chain (mesoDAP3 in B. subtilis) and presence of a side chain consisting of D and L amino acids (L-Lys3-D-iAsn in E. faecium and L-Lys3-L-Ala-L-Ala in E. faecalis) (Fig. 1A). With these three substrates, the cross-linking reaction can potentially lead to the formation of nine dimers, including three homodimers, if the same disaccharide-peptide is used as the donor and the acceptor substrate, and six heterodimers, if different disaccharide-peptides are used in all possible combinations (Table 1). Mass spectrometry analyses of the reaction products indicated that Ldtfm catalyzed formation of a homodimer containing D-iAsn-substituted acceptor and donor stem peptides and of a heterodimer containing stem peptides substituted by L-Ala-L-Ala and D-iAsn (Fig. 3). Tandem mass spectrometry was performed to determine whether the L-Ala-L-Ala-substituted disaccharide-peptide had been used as a donor or an acceptor substrate in the formation of the heterodimer (Fig. 4). Fragmentation was performed on lactoyl-peptides obtained by cleavage of the disaccharide-peptides by alkaline treatment because amino acid sequencing of peptidoglycan dimers is more efficient in the absence of the disaccharide moiety of the molecules (24). This treatment also converts D-iAsn into D-iAsp (24). As detailed in Fig. 4, fragmentation of the heterodimer allowed assigning L-Ala-L-Ala to the free side chain of the donor stem and D-iAsp to the cross-link. Thus, Ldtfm tolerated presence of L-Ala in the donor but not in the acceptor substrate of the cross-linking reaction. The specificity of Ldtfm observed in vitro in the absence of any other cell wall biosynthesis enzyme accounts for the in vivo selection of the acceptor and donor substrates in the derivative E. faecium M512 producing the BppA1 transferase (above).
Of note, interaction of the D,D-transpeptidases (PBPs) with their donor and acceptor substrates has not been extensively investigated with purified PBPs, because the enzymes are generally inactive in vitro (29) except in very special cases involving highly reactive substrates (e.g. thioester) (30) and atypical enzymes (e.g. the soluble R61 D,D-peptidase from Streptomyces spp.) (31, 32). Recently, a peptidoglycan polymerization assay has been developed for the purified PBP1a and 1b of E. coli as these bifunctional enzymes catalyze transglycosylation and transpeptidation of the natural substrate, a dissacharide-peptide linked to undecaprenyl lipid carrier by a phosphodiester bond (lipid II) (33, 34). This approach has not been yet developed for the PBPs of Gram-positive bacteria that use even more complex precursors due to the presence of an additional side chain. Thus, characterization of Ldtfm in the current study represents the first direct in vitro assessment of the substrate specificity of peptidoglycan cross-linking enzyme.
The Ldtfm Homologue from B. subtilis Is Specific for mesoDAP-containing Acceptors but Functions with Various DonorsHaving shown that Ldtfm is specific for its cognate acceptor both in vivo and in vitro, our following aim has been to determine whether Ldtfm homologues from bacteria producing peptidoglycan of different chemotypes are also specific for their respective acceptor. We have started this analysis with the homologue from B. subtilis, LdtBs, because the crystal structure of this protein has been recently solved in the framework of a structural genomics project that did not include functional investigations (21). The full-length LdtBs (167 residues) contains a putative peptidoglycan-binding N-terminal domain consisting of a single LysM module (residues 549, Pfam PF01476) and a C-terminal domain that can be superimposed to the catalytic domain of Ldtfm with a root mean square deviation of 1.21 Å for the 103 C
Ldtfs from E. faecalis Is Specific for Disaccharide-Peptides Containing an L-Ala-L-Ala Side Chain in both the Acceptor and Donor SubstratesThe chromosome of E. faecalis encodes a protein of 474 residues, designated Ldtfs, that is closely related to Ldtfm (37% identity for the catalytic domain). The two proteins display the same domain composition with an overall sequence identity of 29% (Fig. 1C). Ldtfs catalyzed formation of homodimers from the cognate branched disaccharide-tetrapeptide containing L-Lys3-L-Ala-L-Ala (observed monoisotopic mass of 1,987.96, see Table 1 for the calculated mass). Muropeptides containing mesoDAP3 or L-Lys3-D-iAsn were not used for dimer formation indicating that Ldtfs is specific for the L-Ala-L-Ala side chain both in the donor and acceptor positions. Ldtfs Displays L,D-Carboxypeptidase ActivityMS analysis of the product of the L,D-transpeptidation reaction catalyzed by Ldtfs revealed the presence of an additional product (observed monoisotopic mass of 1,916.81) differing from the expected dimer (1,987.97; above) by the loss of one alanyl residue (Fig. 6A). Tandem mass spectrometry indicated that this additional product was a dimer generated by L,D-transpeptidation that lacked D-Ala4 in the acceptor stem (data not shown). The L,D-carboxypeptidase activity of Ldtfs could have cleaved the L-Lys3-D-Ala4 peptide bond in the acceptor stem of the dimer. In addition or alternatively, Ldtfs could have cleaved the substrate prior to its utilization as an acceptor in the cross-linking reaction because a monomer containing a tripeptide stem ending in L-Lys3 was also detected in the reaction mixture. The latter observation indicated that the L,D-transpeptidase and L,D-carboxypeptidase activities of Ldtfs acted in competition because tripeptide stems cannot be used as a donor substrate. In contrast, L,D-carboxypeptidase activity was not detected for Ldtfm from E. faecium (18) and LdtBs from B. subtilis (data not shown). L,D-carboxypeptidases specific for the L-Lys3-D-Ala4 or mesoDAP3-D-Ala4 bond of peptidoglycan precursors have been described in E. coli (36), Pseudomonas aeruginosa (37), and Lactococcus lactis (38). These enzymes are unrelated to Ldtfm and were only shown to have a hydrolytic activity.
Muropeptides Containing a Pentapeptide Stem Are Substrates of LdtfsReplacement of the disaccharide-tetrapeptide substituted by L-Ala-L-Ala by the corresponding pentapeptide in the cross-linking assay led to the formation of hydrolysis and transpeptidation products (Fig. 6B). Ldtfs displayed endopeptidase activity because the enzyme cleaved the L-Lys3-D-Ala4 peptide bond of the pentapeptide, generating a tripeptide and the dipeptide D-Ala-D-Ala. Ldtfs also formed dimers containing a tripeptide stem and a pentapeptide stem at the donor and acceptor position, respectively. Combination of the L,D-transpeptidase and L,D-endopeptidase activity led to the formation of dimers containing two tripeptide stems. In contrast to Ldtfs, the L,D-transpeptidase from E. faecium functions exclusively with acyl donors containing a tetrapeptide stem (18).
Exchange Reactions Catalyzed by LdtfsThe L,D-transpeptidase of E. faecium has been previously shown to cleave the L-Lys3-D-Ala4 peptide bond of an acyl donor substrate and to form a peptide bond between the
ConclusionsBypass of the D,D-transpeptidase activity of the PBPs by the L,D-transpeptidase activity of Ldtfm confers high level cross-resistance to -lactams and glycopeptides in E. faecium because these drugs do not interact with the enzyme and its substrate, respectively (9). Ldtfm is the first functionally characterized member of a novel family of cysteine peptidases that are widespread in both Gram-positive and Gram-negative bacteria (18, 35). We have characterized two additional members of the family from B. subtilis (LdtBs) and E. faecalis (Ldtfs) and shown that these enzymes catalyze the cross-linking of purified peptidoglycan fragments in vitro. Comparison of the specificity of Ldtfm, LdtBs, and Ldtfs (Table 2) indicated that diversification of the structure of peptidoglycan precursors associated with speciation had led to a parallel evolution of the substrate specificity of members of the Ldtfm protein family. This evolution concerns mainly the acceptor because for this substrate all three L,D-transpeptidases were specific for their cognate disaccharidepeptides. In contrast, Ldtfm and LdtBs tolerated substitutions at the third position of the donor. The specificity of the L,D-transpeptidases for the acceptor stem indicates that blocking the assembly of the side chain of peptidoglycan precursors is a potential strategy to combat resistance involving L,D-transpeptidases.
* This work was supported by the program "ACI Microbiologie 2003" from the Fonds National de la Science (Grant ACIM-4-9), the European Community (COBRA, contract LSHM-CT-2003-503335, 6th PCRD), NIAID, National Institutes of Health (Grant R01 AI45626), and the Fondation pour la Recherche Médicale. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 To whom correspondence should be addressed: INSERM U655-LRMA, Université Pierre et Marie Curie Centre de Recherches Biomédicales des Cordeliers, 15 Rue de l'Ecole de Médecine, 75270 Paris, Cedex 06, France. Tel.: 33-1-43-25-00-33; Fax: 33-1-43-25-68-12; E-mail: michel.arthur{at}bhdc.jussieu.fr.
2 The abbreviations used are: GlcNAc, N-acetylglucosamine; PBP, penicillin-binding protein; D-iAsn, D-iso-asparagine; D-iAsp, D-iso-aspartic acid; mesoDAP, meso-diaminopimelic acid; MS, mass spectrometry; MS/MS, tandem mass spectrometry; MurNAc, N-acetylmuramic acid; RP-HPLC, reverse phase high pressure liquid chromatography.
We thank L. Gutmann for helpful comments on the manuscript.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||